UTI Healthcare Fund - Regular Plan - Growth Option
(Erstwhile UTI Pharma & Healthcare Fund-Growth Option)
Fund House: UTI Mutual Fund| Category: Equity: Sectoral-Pharma and Healthcare |
| Launch Date: 05-08-2005 |
| Asset Class: Equity |
| Benchmark: S&P BSE Healthcare TRI |
| Expense Ratio: 2.35% As on (30-04-2021) |
| Status: Open Ended Schemes |
| Minimum Investment: 5000.0 |
| Minimum Topup: 1000.0 |
| Total Assets: 852.5 Cr As on (31-05-2021) |
| Turn over: 63% | Exit Load: 1% for redemption within 30 days |
159.2524
-0.88 (-0.5518%)
14.65%
S&P BSE Healthcare TRI 13.99%
PERFORMANCE
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
Investment Objective
An open-end fund which exclusively invests in the equities of the pharma & healthcare sector companies. This fund is one of the growth sector fund s aiming to invest in companies engaged in business of manufacturing and marketing of bulk drug, formulations and health care products and service.
Current Asset Allocation (%)
Indicators
| Volatility | 15.99 |
| Sharp Ratio | 0.16 |
| Alpha | -3.52 |
| Beta | 1.04 |
| Yield to Maturity | - |
| Average Maturity | - |
PEER COMPARISON
| Scheme Name | Inception Date |
1 Year Return(%) |
2 Year Return(%) |
3 Year Return(%) |
5 Year Return(%) |
10 Year Return(%) |
|---|---|---|---|---|---|---|
| UTI Healthcare Fund - Regular Plan - Growth Option | 05-08-2005 | 51.28 | 43.75 | 23.52 | 13.09 | 14.57 |
| DSP Healthcare Fund - Regular Plan - Growth | 05-11-2018 | 56.52 | 48.64 | - | - | - |
| Nippon India Pharma Fund-Growth Plan-Growth Option | 01-06-2004 | 54.37 | 45.25 | 26.45 | 17.69 | 17.67 |
| Mirae Asset Healthcare Fund -Regular Growth | 05-07-2018 | 53.8 | 47.89 | - | - | - |
| ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option | 05-07-2018 | 53.64 | 45.89 | - | - | - |
| SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH | 14-07-1999 | 53.4 | 44.14 | 23.99 | 10.97 | 17.15 |
| Tata India Pharma & Healthcare Fund-Regular Plan-Growth | 28-12-2015 | 47.97 | 40.07 | 24.41 | 12.89 | - |
| Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | 05-07-2019 | 45.27 | - | - | - | - |
| IDBI Healthcare Fund - Regular Plan - Growth | 22-02-2019 | 42.19 | 38.49 | - | - | - |
Scheme Characteristics
Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.
Riskometer
PORTFOLIO
Market Cap Distribution
Small Cap
20.82%
Others
2.69%
Large Cap
53.24%
Mid Cap
23.25%
Scheme Documents
Tax Benefits of investing in this fund
Long term capital gains (LTCG) tax @10% (plus surcharge, if applicable and cess) without indexation if units held for more than 12 months#
Short term capital gains (STCG) tax @ 15% (plus surcharge, if applicable and cess) if units are held for less than 12 months.
Investor does not pay any tax on dividends but a Dividend Distribution Tax (DDT) is deducted at source @11.648% (10% + 12% surcharge + 4% Health & education cess) **
# Capital gain accrued up to January 31st 2018 is exempt from LTCG tax in respect of units acquired before January 31, 2018 & redeemed on or after April 1, 2018. ** The DDT is to be paid by the mutual fund
